India, Jan. 17 -- US based INVO Bioscience, Inc., a medical device company focused on treating infertility with its FDA-cleared INVOcell(R) product, and Qatar based Medesole, a leading supplier of healthcare products inIndiaand theMiddle East, have announced the signing of a joint venture to operate dedicated INVOcell clinics inIndia.

INVOcell, also known as IVC, is the world's onlyin vivoIntravaginal Culture System, offering patients diagnosed with infertility an effective solution through a simplified, more natural and less costly process than traditional in-vitro fertilization (IVF).

The new joint venture (JV) will operate under the name Medesole INVO Bioscience Private Limited. Under terms of the agreement, INVO Bioscience and Medes...